Article Details
Retrieved on: 2025-02-13 23:06:00
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses stock-related activities involving Nautilus Biotechnology, highlighting significant declines in short interest, institutional investments, and changes in analyst ratings, such as Goldman Sachs downgrading the stock. This illustrates various dynamics within financial and equity markets.
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here